BAM66406 SU11248 Sunitinib is a multitargeted FLT3, PDGFRs, VEGFRs, and Kit kinase inhibitor with Ki of 0.009 and 0.008 µM for Flk-1 and PDGFR. Quantity Price 10 mg 70.00 50 mg 210.00 100 mg 390.00 500 mg 1300.00                 C22H27FN4O2 557795-19-4; 341031-54-7 96+% MFCD09260778

BAM66390 XL184 XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

BAM66391 AC220 AC220 is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ± 0.3 nM and >10 mM for MC4-11 and A375, respectively. Quantity Price 10 mg 270.00 50 mg 670.00 200 mg 1770.00                     C29H32N6O4S 950769-58-1 98+% MFCD18074524

BAM66406 Sunitinib Sunitinib is a multitargeted FLT3, PDGFRs, VEGFRs, and Kit kinase inhibitor with Ki of 0.009 and 0.008 µM for Flk-1 and PDGFR. Quantity Price 10 mg 70.00 50 mg 210.00 100 mg 390.00 500 mg 1300.00                 C22H27FN4O2 557795-19-4; 341031-54-7 96+% MFCD09260778

BAM66390 Cabozantinib XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

[1/3]